Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MindAhead offers an evidence-based digital therapeutic app for people with mild cognitive impairment and mild dementia. The program is based on behavioral activation therapy, which has been shown in clinical studies to significantly reduce the risk of progressive dementia. The app is designed to be accessible, personalized through AI and big data analytics, and easy to use for older adults. It aims to slow cognitive decline by stimulating social, physical, and cognitive activity. Clinical research cited by the company shows that participants using behavioral activation were half as likely to show deterioration in cognition over two years compared with controls.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MindAhead.